Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02161263 · ClinicalTrials.gov registry record
Quality of Vision and Quality of Life With LASIK
A clinical trial of Myopia and Astigmatism, sponsored by Edward E. Manche.
- Completed
- Registry status
- 49
- Enrollment target
- 1
- Study location
NCT02161263: Completed study of Myopia and Astigmatism, sponsored by Edward E. Manche.
NCT02161263 is a study of Myopia and Astigmatism that has completed, run by Edward E. Manche. The registered enrollment target is 49 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02161263, a study of Myopia and Astigmatism, has completed, sponsored by Edward E. Manche.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are administering a validated questionnaire looking at patient reported quality of life and quality of vision after LASIK surgery
Primary Outcome
Patients will complete questionnaires preoperatively and postoperatively at month twelve.
Conditions Studied
Interventions
- OTHER Patient Quality of Life andVision after LASIK Surgery
Study Locations (1)
California
- Stanford Eye Laser Center - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2014-03-01 |
| Est. Completion | 2023-02-01 |
What the finished NCT02161263 record still lists
NCT02161263 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Patient Quality of Life andVision after LASIK Surgery is the first listed.
NCT02161263 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02161263 about?
NCT02161263 is a clinical study titled "Quality of Vision and Quality of Life With LASIK". The investigators are administering a validated questionnaire looking at patient reported quality of life and quality of vision after LASIK surgery
What is the current status of trial NCT02161263?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2014-03-01. Estimated completion is 2023-02-01.
What conditions does trial NCT02161263 study?
This clinical trial studies the following conditions: Myopia, Astigmatism, Quality of Lifte.
What interventions are being tested in trial NCT02161263?
The interventions under investigation include: Patient Quality of Life andVision after LASIK Surgery (OTHER).
Who is sponsoring clinical trial NCT02161263?
This trial is sponsored by Edward E. Manche, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02161263 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02161263's enrollment target sits among peer trials
49 76th of 90 higher than 15 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI